MEDALIST Trial: The Need for Blood Transfusions Was Reduced in Myelodysplastic Syndrome Patients
Dr. Pierre Fenaux, of Hôpital Saint Louis, Paris and lead author of the MEDALIST trial, told Ash Clinical News that treatment with the investigational drug, luspatercept, improved the rate of…